µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© y 2cL2c$BT
a5>)?m
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© Qh
1q
1.Co-stimulators (or co-stimulating molecules) hq]xmM?&
2.NK-kB +i_'gDy$
3.Immunoglobulin superfamily #?A]v>I;C
4.antigen-presenting cell (APC) #%:`p9p.S
5.death domain d~vTD|
Et
6.CCR and CXCR 9PUa?Bc`=
7.Lectin (or mitogen) CL
EpB2_
8.Clusters of differentiation, CD) 1mY+0
9.B7 family wK2yt?
10.Cytotoxic T lymphocyte, CTL) ^!$}
BY
11.IL-15 and IL-15 receptor (IL-15R) R Co eJ|
12.MHC restriction >a?OXqYP
13.Affinity-chromatography YG-Z.{d5Z
14.Cyctosprin A, CsA %H 8A=
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 7W6eiUI'
MT;SRAmUr
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Fl8w7LcF7
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 \.K\YAM<
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ i5ajM,i/K
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ bbE bf !E
#
q0Ub-
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© '*o7_Ez-{
?/o2#iJx
ÃâÒßѧרҵ£º ws*~$x?7
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ T#MA#H2
J=f:\]@Oy
Ïû»¯ÄÚ¿Æ£º N#<zEAB
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ &:!ZT=
+YGw4{\EL
ѪҺ²¡Ñ§×¨Òµ£º { r<(t#
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿